Form 4 for AORT ARTIVION, INC.
Accepted 2023-02-21 00:00:00 ET · period of report 2023-02-17 · accession 0000784199-23-000024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-21 | 2023-02-17 | AORT | Horton Amy | VP, CAO | M - OptEx | $10.24 | +20.7K | 117.7K | +21% | +$212.1K |
| DM | 2023-02-21 | 2023-02-17 | AORT | Horton Amy | VP, CAO | S - Sale+OE | $14.09 | -18.0K | 102.7K | -15% | -$253.6K |
| DM | 2023-02-21 | 2023-02-17+ | AORT | Horton Amy | VP, CAO | F - Tax | $13.96 | -1,728 | 102.3K | -2% | -$24.1K |
| DM | 2023-02-21 | 2023-02-17 | AORT | Horton Amy | VP, CAO | M - OptEx | $10.24 | -20.7K | 0 | -100% | -$212.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-17 | M | A | 3,000 | $10.24 | 105,663 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2022 |
| 2 | Common | Common Stock | 2023-02-17 | S | D | 15,000 | $14.08 | 102,663 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2022 (F2) Reflects weighted average price. Range of prices were between $13.79 to $15.18. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full informationregarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2023-02-19 | F | D | 258 | $13.96 | 100,935 | D | — | — | (F4) These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. |
| 4 | Common | Common Stock | 2023-02-19 | F | D | 1,107 | $13.96 | 101,193 | D | — | — | (F5) Represent shares of restricted stock that were withheld for taxes on the grant vest date. |
| 5 | Common | Common Stock | 2023-02-17 | F | D | 363 | $13.96 | 102,300 | D | — | — | (F4) These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. |
| 6 | Common | Common Stock | 2023-02-17 | S | D | 3,000 | $14.13 | 102,663 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2022 (F3) Reflects weighted average price. Range of prices were between $13.65 to $15.18. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full informationregarding the number of shares sold at each separate price |
| 7 | Common | Common Stock | 2023-02-17 | M | A | 17,713 | $10.24 | 117,663 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2022 |
| 8 | Derivative | Stock Options (Right to buy) | 2023-02-17 | M | D | 3,000 | $10.24 | 0 | D | $10.24 · 2017-02-19 to 2023-02-19 | 3,000 Common Stock | (F6) Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2017. |
| 9 | Derivative | Stock Options (Right to buy) | 2023-02-17 | M | D | 17,713 | $10.24 | 0 | D | $10.24 · 2017-02-19 to 2023-02-19 | 17,713 Commn Stock | (F6) Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2017. |